Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more

Cancer immunotherapy attempts to harness the immune system by breaking tolerance and generating a robust anticancer response. We have recently demonstrated a synergistic enhancement in tumor clearance following therapeutic, dual PD-1 and LAG-3 blockade. Here, we discuss the implications of these fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Turnis, Meghan E., Korman, Alan J., Drake, Charles G., Vignali, Dario A.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494635/
https://www.ncbi.nlm.nih.gov/pubmed/23170269
http://dx.doi.org/10.4161/onci.20593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494635/
https://www.ncbi.nlm.nih.gov/pubmed/23170269
http://dx.doi.org/10.4161/onci.20593

Ejemplares similares